

© 2025 LYNX-Werbemitteilung - Bitte beachten Sie den Haftungsausschluss
Realtime | Geld | Brief | Zeit |
---|---|---|---|
86,40 | 88,16 | 11.05. | |
86,74 | 87,18 | 09.05. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mi | Jazz Pharmaceuticals plc - 10-Q, Quarterly Report | ||
Di | Jazz Pharmaceuticals plc - 8-K, Current Report | ||
Di | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance | - Total revenues of $898 million in 1Q25 -- Xywav® and Epidiolex® revenues grew 9% and 10% year-over-year, respectively, in 1Q25 -- Completed submission of sNDA for Zepzelca® in 1L ES-SCLC... ► Artikel lesen | |
Di | Avadel Pharma gains after appeals court ruling in Lumryz case with Jazz Pharma | ||
05.05. | Jazz Pharmaceuticals Q1 2025 Earnings Preview |